Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2017 1
2019 2
2020 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial.
Ponsioen CY, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Bossuyt PMM, Hart A, Warusavitarne J, Buskens CJ, van Bodegraven AA, Brink MA, Consten ECJ, van Wagensveld BA, Rijk MCM, Crolla RMPH, Noomen CG, Houdijk APJ, Mallant RC, Boom M, Marsman WA, Stockmann HB, Mol B, de Groof AJ, Stokkers PC, D'Haens GR, Bemelman WA; LIR!C study group. Ponsioen CY, et al. Among authors: noomen cg. Lancet Gastroenterol Hepatol. 2017 Nov;2(11):785-792. doi: 10.1016/S2468-1253(17)30248-0. Epub 2017 Aug 31. Lancet Gastroenterol Hepatol. 2017. PMID: 28838644 Clinical Trial.
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial.
Stevens TW, Haasnoot ML, D'Haens GR, Buskens CJ, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Mol B, Stokkers PCF, Bemelman WA, Ponsioen CY; LIR!C study group. Stevens TW, et al. Lancet Gastroenterol Hepatol. 2020 Oct;5(10):900-907. doi: 10.1016/S2468-1253(20)30117-5. Epub 2020 Jun 30. Lancet Gastroenterol Hepatol. 2020. PMID: 32619413 Clinical Trial.
Update on genetics in inflammatory disease.
Noomen CG, Hommes DW, Fidder HH. Noomen CG, et al. Best Pract Res Clin Gastroenterol. 2009;23(2):233-43. doi: 10.1016/j.bpg.2009.02.005. Best Pract Res Clin Gastroenterol. 2009. PMID: 19414149 Review.
Vulvar and vaginal neoplasia in women with inflammatory bowel disease.
Rouvroye MD, Tack GJ, Mom CH, Lissenberg-Witte BI, Pierik MJ, Neefjes-Borst EA, de Boer NKH; Dutch Workgroup on IBD and Vulvovaginal neoplasia. Rouvroye MD, et al. Dig Liver Dis. 2020 Feb;52(2):149-155. doi: 10.1016/j.dld.2019.10.002. Epub 2019 Nov 11. Dig Liver Dis. 2020. PMID: 31718933
Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: the LIR!C Trial.
de Groof EJ, Stevens TW, Eshuis EJ, Gardenbroek TJ, Bosmans JE, van Dongen JM, Mol B, Buskens CJ, Stokkers PCF, Hart A, D'Haens GR, Bemelman WA, Ponsioen CY; LIR!C study group. de Groof EJ, et al. Gut. 2019 Oct;68(10):1774-1780. doi: 10.1136/gutjnl-2018-317539. Epub 2019 Feb 1. Gut. 2019. PMID: 31233395 Clinical Trial.
Gastroduodenal Crohn's disease and pancreatitis.
Noomen CG, Veenendaal RA, Verspaget HW. Noomen CG, et al. Gastroenterol Hepatol (N Y). 2008 Jul;4(7):496-8. Gastroenterol Hepatol (N Y). 2008. PMID: 21960927 Free PMC article. No abstract available.